African COVID -19Vaccine Hesitancy – ACHES
Vaccine hesitancy is defined by the WHO’s Strategic Advisory Group of Experts on Immunization as a ’delay in acceptance or refusal of vaccination despite availability of vaccination services’. This varies in form and intensity based on when and where it occurs and what vaccine is involved. Several prophylactic vaccines against COVID-19 are currently available. As the world is beginning the rollout the first approved vaccines, little is known about people’s potential acceptance of a COVID-19 vaccine in most of the African countries. ACHES (African COVID -19Vaccine Hesitancy) is an observational study aimed at measuring COVID-19 vaccine hesitancy in five west African countries and exploring causes behind the hesitancy with the main objective of informing guidelines for the proficient roll-out of the vaccines in the region.
Institut de Recherche en Sciences de la Santé (IRSS/CNRST)- Burkina Faso, Santé Plus- Guinea, Faculté de Médecine et d’Odonto - stomatologie (FMOS) & University Clinical Research Center (UCRC), Université des Sciences, des Techniques et des Technologies de Bamako (USTTB) - Mali, Université Cheikh Anta Diop de Dakar (UCAD)- Senegal and University of Sierra Leone, College of Medical and Allied Health Sciences (COMAHS)- Sierra Leone.
@BNITM Dewi Ismajani Puradiredja –Ricardo Strauss-Ralf Krumkamp
Global Health Protection Programme (GHPP) via the German ministry of health (BMG)
March 2021-August 2022